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Abstract Triply-fused 1,3-diazepine derivatives have been obtained by acidic reduction of 
rotationally locked and sterically hindered nitro groups in the presence of an aldehyde or 
ketone. The nitro groups are sited on adjacent rings of a dicyanodibenzothiophene-5,5-
dioxide which also displays fully reversible two-electron accepting behavior. The synthesis, 
crystallographically determined molecular structures and aspects of the electronic properties 
of these new molecules are presented.  
Developing new routes to underexplored heterocyclic motifs is a fundamental driving force in 
organic chemistry and is essential to identifying new structures of medicinal or technological 
value. Diazepines are of major pharmaceutical importance.
1–3
 1,2- and 1,4-benzodiazepines in 
particular comprise entire classes of drugs, including the anti-anxiety medications tofisopam 
(strictly a 2,3-diazepine) and diazepam.
4–8
 1,3-Diazepines, and the saturated analogues 1,3-
diazepanes, are less prevalent; however they have been studied as HIV protease inhibitors,
9–14
 
as anti-cancer
15–20
 and anti-viral agents,
15,21–28
 and also as N-heterocyclic carbene ligands.
29,30
 
In comparison with 1,2- and 1,4-diazepines, routes to 1,3-diazepines are less clearly 
established. Since the last comprehensive survey of their synthesis
31
 only a handful of new 
synthetic approaches have been reported for monocyclic,
32–35
 singly-
36–39
 or doubly-ring-
fused 1,3-diazepines.
40–49
  
In this work the introduction of sterically hindered nitro groups at the 1- and 9-positions of a 
dibenzothiophene-5,5-dioxide derivative provides access to a new two-electron accepting 
molecule, which is a precursor to luminescent four-ring-fused 2,3-dihydro-1,3-diazepines 6-8 
using facile protocols in synthetically viable yields. To our knowledge these molecules 
represent the first examples of tetracyclic 1,3-diazepine derivatives. 
 
Scheme 1. Synthesis of the new acceptor 5 and its X-ray molecular structure. 
The synthesis of the new dibenzothiophene-5,5-dioxide acceptor is shown in Scheme 1. 
Simultaneous cyclization and acidic hydrolysis of dimethyl biphenyl-4,4‟-dicarboxylate 1 
was achieved in refluxing chlorosulfonic acid according to the procedure of Olkhovik et al to 
produce the diacid 2.
50
 In the same report, mononitration of 2 at the 1-position was 
performed, therefore, by using the more concentrated fuming nitric acid and extending the 
reaction time dinitration was achieved to produce 1,9-dinitrodibenzothiophene-5,5-dioxide-
3,7-dicarboxylic acid 3. A byproduct containing a nitro group in the 2-position was reported 
for the mononitration;
50
 however, we did not observe this during our dinitration process. 
Finally, the carboxylic acid groups of 3 were easily converted to nitriles using standard 
procedures. Reaction of 3 with an excess of refluxing SOCl2 and a catalytic amount of N,N-
dimethylformamide (DMF) gave the presumed diacyl chloride derivative, which was reacted 
immediately with aqueous ammonia to produce the diamide derivative 4, which had low 
solubility. Compound 4 was then dehydrated with POCl3 to give 5. Each step in Scheme 1 is 
straightforward to perform relying upon simple precipitation and filtration to isolate products. 
The overall yield is 54% for the five-step sequence to compound 5.  
Considerable twisting of the aromatic skeleton of 5 occurs due to a combination of steric 
hindrance and repulsive electronic effects between the nitro groups. Relief of this ring-strain 
should be a useful driving force in exploiting the reactivity of these nitro groups towards 
producing new heterocycles. Indeed, reduction of the nitro groups of 5 in the presence of 
aldehydes or ketones provides convenient access to the brightly colored 2,3-dihydro-1,3-
diazepines 6‒8 featuring alkyl or aromatic substituents at the 2-position, via the diamine 9 
(Scheme 2). 
 
Scheme 2. Synthesis of tetracyclic 1,3-diazepines 6, 7 and 8 from 5 via intermediate diamine 
9, and the X-ray molecular structure of 6.   
Acidic reduction of 5 using SnCl2.2H2O in the presence of acetone provided the N,N’-
isopropylidene-2,3-dihydro-1,3-diazepine derivative 6. The modest yield (45%) is offset by 
the straightforward practical protocol. To confirm the intermediacy of the diamine 9 in this 
process a separate experiment was performed in which 9 was isolated, albeit in only 14% 
yield, and then cyclized in acidic acetone to provide 6 in 78% yield. The one-pot approach is, 
therefore, much more expedient than performing the reduction and cyclization sequentially, 
due to difficulties in isolating the diamine 9. Analogous one-pot reactions using 
cyclohexanone and 4-tert-butylbenzaldehyde gave 7 and 8, respectively, in 44% and 39% 
yields. 
We note that electrochemical reduction of 2,2‟-dinitrobiphenyl in the presence of 
aldehydes and ketones has previously been used to produce 1,3-diazepines.
51
 However, the 
reaction conditions reported above for converting 9 into 6 did not work with 2,2‟-
dinitrobiphenyl; no diazepine was isolated and the only major product identified was 2,2‟-
diaminobiphenyl. This agrees with a previously reported high yielding, tin-mediated, 
reduction of this
52
 and related compounds.
53,54
 We are aware of one example of a reductive 
cyclization of a 2,2‟-dinitrobiaryl using SnCl2 and an identical reaction stoichiometry to the 
present work which resulted in trace (5%) benzo[c]cinnoline formation.
55
 These results 
indicate that the structurally enforced proximity of the two amino groups in 9 is required for 
efficient reductive cyclization.  
 
Figure 1. Absorption (solid line) and emission spectra (dashed line) for compounds 5‒8 in 
MeCN solution. 
The diazepines 6‒8 were brightly colored and emissive in both the solid state and in 
solution, unlike the precursor 5 which is non-emissive. Absorption and emission spectra in 
acetonitrile are shown in Figure 1 and summarized in Table S1. The absorption and emission 
in the visible region for 6‒8 is probably due to strong intramolecular charge transfer between 
the electron rich diazepine and electron poor dibenzothiophene-5,5-dioxide regions. This 
postulation is strengthened by solvatochromism observed as a blue shift in emission of up to 
26 nm when moving from highly polar acetonitrile (r = 37.5) to less polar chloroform (r = 
4.81, Figure S1 and Table S1). There is a substantial difference in color between the ketone 
products 6 and 7 (orange) and aldehyde product 8 (yellow).  
The molecular structures of 5 (in three different crystal forms) and 6 were determined 
by single-crystal X-ray diffraction (see SI) and, in good agreement, calculated using density 
functional theory (DFT, B3LYP/6-31G*).  Both methods show molecule 5 adopting a twisted 
conformation of the dibenzothiophene system, in order to widen the short contacts N…N and 
N…O between adjacent nitro-groups (Table 1), whereas in 6 the dibenzothiophene unit is 
practically planar, N(2) and N(3) are coplanar with it and their (post-cyclization) separation is 
much shorter than in 5, the C6-C7 bond also shortening slightly. The 1,3-diazepine ring of 6 
adopts a half-chair conformation with the N2-C15-N3 fragment inclined to the 
dibenzothiophene plane by 51.5(1)° (cf. calculated 34.6°). The accurate prediction of 
structures 5 and 6 by DFT analysis encouraged us to perform it for 9 whose single crystals 
could not be obtained. The predicted structure is intermediate between those of 5 and 6 
(Figure S5, Table 1). 
Table 1. Experimental and calculated torsion angles (°) and interatomic distances (Å)
a
 
Molecule 5 6 9 
C5-C6-C7-C8 / DFT 18.2 0 16.3 
X-ray 18.0-23.5 1.2 - 
C1-C6-C7-C12 / DFT 13.1 0 8.7 
X-ray 12.0-14.4 0.7 - 
N2…N3 / DFT 2.997 2.411 2.774 
X-ray 2.901(3)-3.001(2) 2.425(2) - 
N2…O5 / DFT 2.681 -  
X-ray 2.587(7)-2.717(2) - - 
C6-C7 / DFT 1.490 1.474  
X-ray 1.486(2)-1.494(4) 1.472(2) - 
a
 For atom numbering see Schemes 1 and 2.  
 
Figure 2. HOMO (lower) and LUMO (upper) contours for 5 and 6 and their calculated 
energies. 
Molecular orbital distributions for 5 and 6 (Figure 2) show a major contribution to the 
LUMO of 5 from the nitro groups, the nitrogen atoms of which subsequently become HOMO 
contributors upon reduction and cyclization to 6. The results of identical calculations for 9 are 
shown in Figure S6. 
Electrochemistry 
 Figure 3. Cyclic voltammetry of 5  
An interesting feature of the diazepine precursor compound 5 is its ability to accept 
two electrons as shown in cyclic voltammetry (CV) experiments. The voltammogram in 
Figure 3 shows two, sequential, single-electron reductions at half wave potentials of ‒0.15 
and ‒0.45 V. Both processes are cleanly reversible displaying a linear dependence between 
peak current and the square root of the scan rate (Figures S8 and S9) and peak separations 
close to the 59 mV expected for a 1-electron wave. The data are summarized in Table S4 
alongside a more detailed discussion of the properties of 5 in comparison with some related 
fluorenone based acceptors.
56
  
In conclusion, an efficient synthetic route has been established to an unusual highly-
functionalized fused-ring 2,3-dihydro-1,3-diazepine system from the key dinitro compound 5 
based on a one-pot reduction followed by reaction with aldehyde or ketone functionality. A 
comparison with 2,2‟-dinitrobiphenyl shows that the structurally-enforced proximity of the 
two amino groups in 9 is required for diazepine formation. There is scope to exploit this 
chemistry in the synthesis of other interesting products. For example, the close proximity of 
the nitro groups in 5 suggests that ring closure to benzo[c]cinnoline type scaffolds may also 
be feasible using alternative reaction conditions,
57–59
 while other suitably nitrated carbo- and 
heterocycles such as fluorenes or carbazoles might behave similarly to 5, providing further 
structural diversity for fused-ring 1,3-diazepines. 
EXPERIMENTAL 
General methods. All reactions requiring an inert atmosphere were performed under a 
blanket or argon or nitrogen gas which was dried though a column of phosphorus pentoxide. 
Anhydrous solvents were dried through an HPLC column on an innovative Technology Inc. 
solvent purification system. All reactants and reagents were purchased from commercial 
suppliers and used without further purification unless otherwise stated. Column 
chromatography was carried out using silica gel 60: 40-60 µm mesh (Fluorochem). 
Analytical thin-layer chromatography was performed on precoated aluminium silica gel 60 
F254 plates (Merck) which were approximately 2x6 cm in size and visualization was made 
using ultraviolet light (254/365 nm). NMR spectra were recorded on: Bruker Avance-400 (
1
H 
NMR (400 MHz), 
13
C (101 MHz) Varian Inova-500 (
13
C NMR (125MHz) and Varian 
VNMRS-700 (
1
H (700 MHz), 
13
C (175 MHz)) NMR spectrometers. Chemical shifts are 
reported in ppm downfield of tetramethylsilane (TMS) using TMS or the residual solvent as 
an internal reference. NMR spectra were processed using MestreNova. Multiplicities are 
reported as singlet (s), doublet (d), triplet (t), and multiplet (m). Melting points were 
determined in open-ended capillaries using Stuart Scientific SMP3 melting point apparatus at 
a ramping rate of 1 °C/min. They are recorded to the nearest 1 °C and are uncorrected. Mass 
spectrometry data were generated by Waters Ltd, UK (atmospheric solids analysis probe 
(ASAP) mass spectrometry). IR spectra were collected on a Perkin-Elmer Spectrum Two IR 
spectrometer. Elemental analyses were obtained on an Exeter Analytical Inc. CE-440 
elemental analyzer. Cyclic voltammetry was recorded using a Princeton Applied Research 
VersaSTAT 3. Glassy carbon disk, Pt wire and Ag/Ag
+
 (AgNO3 in acetonitrile) were used as 
the working, counter and reference electrodes respectively. Measurements were corrected to 
the ferrocene/ferrocenium redox couple as an internal standard and represented versus 
Ag/AgCl which occurred at ‒0.45 V versus Fc/Fc+ in these conditions. Acetonitrile was used 
as the solvent with an analyte molarity of ca. 10
-4 
M in the presence of 1  10-3 M (n-
Bu4N)(PF6) as supporting electrolyte. Solutions were degassed with Ar and experiments run 
under a blanket of Ar. UV/Vis absorbance spectra were measured using a UV-1800 UV-Vis 
Spectrophotometer (Shimadzu) and UVProbe version 2.33 software. Emission spectra were 
recorded on an SPEX Fluoromax luminescence spectrometer using dM300 version 3.12 
software. Density function theory (DFT) calculations were performed with ORCA v4.01
60
 
using the B3LYP hybrid functional and 6-31G* basis set.
61–63
 Ground state structural 
optimizations were performed prior to frontier orbital calculations. 
5,5-Dioxo-5H-dibenzo[b,d]thiophene-3,7-dicarboxylic acid (2):
50
 A solution of dimethyl 
biphenyl-4,4‟-dicarboxylate 1 (5.00 g, 19.0 mmol) in chlorosulfonic acid (20 mL) was heated 
at reflux for 3 h. The reaction mixture was cooled to room temperature and poured over ice to 
precipitate the product. The white precipitate was filtered and washed with water (50 mL), 
hexane (40 mL) and diethyl ether (40 mL). The white powder was recrystallized from 
acetone to afford 2 as a white crystalline solid (5.51 g, 95%). Mp: > 350 °C; 
1
H NMR (400 
MHz, DMSO-d6, ppm) δ = 8.43 (2H, d, J = 7.7 Hz, H1/9), 8.38 (2H, d, J = 0.9 Hz, H4/6), 8.36 
(2H, dd, J = 8.0, 1.5 Hz, H2/8). 
1,9-Dinitro-5,5-dioxo-5H-dibenzo[b,d]thiophene-3,7-dicarboxylic acid (3): A 1 L two-
necked round bottom flask equipped with a water cooled reflux condenser and a pressure 
equalizing dropping funnel was charged with 2 (18.0 g, 59.2 mmol) and 95% sulfuric acid (d 
= 1.83, 165 mL) and placed in an ice batch. Fuming 90% nitric acid (d = 1.50, 250 mL) was 
added cautiously using to the stirred solution through the dropping funnel while maintaining 
the temperature between 5‒10 °C. The ice bath was swapped for a heating block which was 
then slowly heated to 130 °C for 48 h. To minimize corrosive vapors escaping the reaction 
vessel the top of the reflux condenser was connected by PVC tubing to an empty 500 mL 
Dreschel bottle (to avoid the risk of suck back into the reaction vessel) which in turn was 
connected by another length of PVC tubing the end of which was submerged approximately 2 
cm below the surface of 400 mL of water in a 1 L beaker. After heating, the mixture was 
allowed to cool then poured over ice. The white precipitate that formed was filtered and 
washed with water (60 mL) then hexane (40 mL). The crude product was recrystallized from 
acetic acid to afford 3 as a white crystalline solid (17.1 g, 73%). Mp: >350 °C; 
1
H NMR (400 
MHz, DMSO-d6, ppm) δ = 8.89 (2H, d, J = 1.5 Hz, H2/8), 8.71 (2H, d, J = 1.5 Hz, H4/6); 
13
C 
NMR (101 MHz, DMSO-d6, ppm) δ = 163.6, 146.3, 141.0, 137.0, 131.1, 127.1, 123.9; IR 
(νmax/cm
-1
 ) 3095 (w), 2523 (br), 1707 (s, C=O), 1543 and 1359 (s, NO2), 1326 and 1146 (s, 
SO2), 1279 (s), 1185 (s), 1172 (s), 744 (s); MS (ASAP) m/z: 395.0 [M + H]
+
; HRMS (ASAP) 
m/z: [M + H]
+
 Calcd for C14H7N2O10S 394.9816; Found 394.9811. 
1,9-Dinitro-5,5-dioxo-5H-dibenzo[b,d]thiophene-3,7-dicarboxamide (4): A few drops of 
DMF were added to a suspension of 3 (15.0 g, 38.0 mmol) in thionyl chloride (380 mL) 
which was then heated to reflux for 3 h to form a yellow solution. Upon cooling to room 
temperature the excess thionyl chloride was removed under reduced pressure to afford a pale 
yellow solid (16.4 g, 38.0 mmol). The yellow solid was then suspended in water (20 mL) 
with stirring before 35% aqueous ammonia solution (d = 0.88, 200 mL) was very carefully 
added dropwise (CAUTION! gas evolution). The reaction mixture was left to stir at room 
temperature for 2.5 h then poured over ice to produce a brown precipitate which was filtered 
off and washed with diethyl ether (50 mL) then hexane (50 mL) to yield 4 as a pale brown 
solid (12.7 g, 86%). The compound was used without further purification. Mp: 230 °C (dec.); 
1
H NMR (400 MHz, DMSO-d6, ppm) δ = 8.96 (2H, d, J = 1.0 Hz, H2/8), 8.81 (2H, d, J = 1.0 
Hz, H4/6), 8.61 (2H, s, ‒NH), 8.12 (2H, s, ‒NH); 
13
C NMR (101 MHz, DMSO-d6, ppm) δ = 
163.3, 146.2, 140.7, 139.6 , 129.9, 125.4, 122.9; IR (νmax/cm
-1
 ) 3083 (br), 2924 (w), 1693 (s, 
C=O),  1616 (m, amide‒H) 1541 and 1352 (s, NO2), 1314 and 1145 (s, SO2), 1386 (m), 1192 
(m); MS (ASAP) m/z: 393.0 [M + H]
+
;  HRMS (ASAP) m/z: [M + H]
+ 
Calcd for 
C14H9N4O8S 393.0136; Found 393.0135. 
3,7-Dicyano-1,9-dinitro-5,5-dioxo-5H-dibenzo[b,d]thiophene (5): A solution of 4 (1.60 g, 
4.08 mmol) in phosphorus oxychloride (40 mL) was heated to reflux for 3 h. The resulting 
dark orange solution was cooled to room temperature and quenched slowly with warm water. 
The orange precipitate was filtered and washed with water (50 mL) and hexane (30 mL). The 
crude product was recrystallized from acetonitrile and water to afford 5 as pale yellow 
crystals (1.30 g, 90%). Mp: 250 °C (dec.); Elemental Anal. Calcd for C14H4N4O6S: C 47.20, 
H 1.13 N 15.73, Found: C 46.84, H 1.12, N 15.70; 
1
H NMR (400 MHz, acetone-d6, ppm) δ = 
9.08 (2H, d, J = 1.5 Hz, H2/8), 9.02 (2H, d, J = 1.5 Hz, H4/6); 
13
C NMR (101 MHz, acetone-d6, 
ppm) δ = 147.9, 142.8, 135.4, 131.6, 125.5, 119.0, 115.8; IR (νmax/cm
-1
 ) 3074 (w), 2242 
(C≡N, w), 1547 and 1352 (NO2, s), 1495 (m), 1330 and 1161 (SO2, s), 1227 (m), 1188 (m), 
778 (m), 737 (s), 694 (s), 575 (m), 544 (s), 467 (s). Despite repeated attempts using a range of 
techniques, this molecule was not observed by mass spectrometry. Single crystals for X-ray 
analysis were grown from both ethyl acetate/hexane and THF/MeOH/H2O solutions. 
N,N'-isopropylidene-1,9-diamino-3,7-dicyano-5,5-dioxo-5H-dibenzo[b,d]thiophene (6): 
To a stirred solution of SnCl2.2H2O (3.00 g, 13.4 mmol) in a mixture of methanol (8.50 mL) 
and aqueous HCl (2 M, 8.5 mL), acetone (1.00 mL, 13.6 mmol, 16 eq.) and 5 (0.30 g, 0.84 
mmol) were added sequentially. The mixture was then heated to 85 °C for 2.5 h. The mixture 
was cooled to room temperature and poured into aqueous HCl (2 M, 34 mL). An orange 
precipitate immediately formed which was filtered and washed with hexane (30 mL). It was 
then purified by silica column chromatography (eluent: 30:70 hexane: ethyl acetate (v/v)) to 
afford 6 as an orange powder (128 mg, 45%). Mp: 350 °C (dec.);
 1
H NMR (400 MHz, 
acetone-d6, ppm) δ = 7.64 (2H, d, J = 1.3 Hz, H4/6), 7.44 (2H, d, J = 1.3 Hz, H2/8), 6.98 (2H, s, 
‒NH‒), 1.63 (6H, s, ‒CH3); 
13
C NMR (101 MHz, acetone-d6, ppm) δ = 146.1, 140.2, 126.9, 
119.1, 118.0, 114.6, 114.3, 67.2, 28.4; IR (νmax/cm
-1
 ) 3331 (N‒H, m), 2917 (w), 2233 (C≡N, 
m), 1740 (m), 1606 (m), 1526 (m), 1457 (m), 1367 (m), 1308 and 1150 (SO2, s), 1278 (m), 
1028 (m), 876 (m), 713 (m), 624 (m), 545(s); MS (ASAP) m/z: 337.1 [M + H]
+
; HRMS 
(ASAP) m/z: [M + H]
+
 Calcd. for C17H13N4O2S 337.0754; Found 337.0753. 
N,N'-cyclohexylidene-1,9-diamino-3,7-dicyano-5,5-dioxo-5H-dibenzo[b,d]thiophene (7): 
To a stirred solution of SnCl2.2H2O (5.07 g, 22.5 mmol) in a mixture of methanol (14 mL) 
and aqueous HCl (2 M, 14 mL), cyclohexanone (0.73 mL, 7.0 mmol) and 5 (0.50 g, 1.40 
mmol) were added. The mixture was then heated to 85 °C for 2.5 h. The mixture was cooled 
to room temperature and poured into aqueous HCl (2 M, 56 mL). An orange precipitate 
immediately formed which was filtered and washed with hexane (30 mL). It was then 
purified by silica column chromatography (eluent: 40:60 hexane: ethyl acetate (v/v)) to afford 
7 as small orange crystals (230 mg, 44%). Mp: 300 °C (dec.); 
1
H NMR (400 MHz, acetone-
d6, ppm) δ = 7.64 (2H, d, J = 1.3 Hz, H4/6), 7.59 (2H, d, J = 1.3 Hz, H2/8), 6.84 (2H s, ‒NH‒), 
1.92 – 1.84 (4H, m, ‒CH2‒), 1.69 – 1.49 (6H, m, ‒CH2‒); 
13
C NMR (101 MHz, acetone-d6, 
ppm) δ = 145.5, 140.1, 127.2, 119.6, 118.0, 114.7, 114.3, 68.8, 36.1, 25.8, 22.4; IR (νmax/cm
-1
 
) 3401 (m), 3356 (m), 3321 (N‒H, m), 3076 (w), 2941 (w), 2241 (C≡N, m), 1606 (m), 1517 
(s), 1305 and 1150 (SO2, s) 852 (m), 708 (m), 620 (m); MS (ASAP) m/z: 377.1 [M + H]
+
; 
HRMS (ASAP) m/z: [M + H]
+ 
Calcd. for C20H17N4O2S 377.1067; Found: 377.1067. 
N,N'-(4-tert-butylbenzylidene)-1,9-diamino-3,7-dicyano-5,5-dioxo-5H-
dibenzo[b,d]thiophene (8): To a stirred solution of SnCl2.2H2O (2.02 g, 8.99 mmol) in a 
mixture of methanol (6 mL) and aqueous HCl (2 M, 6 mL), 4-tert-butylbenzaldehyde (0.50 
mL, 2.81 mmol) and 5 (0.20 g, 0.56 mmol) were added. The mixture was then heated to 85 
°C for 2.5 h. The mixture was cooled to room temperature and poured into aqueous HCl (2 
M, 25 mL). The organics were then extracted into ethyl acetate (3 x 15 mL) and washed with 
water (2 x 25 mL). The organic fractions were dried over magnesium sulfate and the ethyl 
acetate removed under vacuum to afford an oil. The oil was dissolved in dichloromethane (30 
mL) and hexane (20 mL) was added. The solvent was reduced in volume (ca. 10 mL) to 
precipitate the crude product as a yellow powder. It was then purified by silica column 
chromatography (eluent: 70:30 hexane: ethyl acetate (v/v)) to afford 8 as a yellow crystalline 
powder (92 mg, 39%). Mp: 300 °C (dec.); 
1
H NMR (400 MHz, acetone-d6, ppm) δ = 7.69 
(2H, d, J = 1.4 Hz, H4/6), 7.65 (2H, d, J = 1.4 Hz, H2/8), 7.58 – 7.48 (4H, m, H
4-t-BuC6H4), 7.17 
(2H, s, ‒NH‒), 5.34 (1H, s, ‒CH‒), 1.36 (9H, s, ‒CH3); 
13
C NMR (101 MHz, acetone-d6, 
ppm) δ = 153.2, 148.5, 140.7, 136.7, 128.3, 126.9, 126.4, 118.9, 118.0, 115.2, 113.8, 71.2, 
35.3, 31.6; IR (νmax/cm
-1
 ) 3355 (N‒H, w), 3063 (w), 2956 (w), 2233 (C≡N, m), 1605 (m), 
1505 (s), 1468 (s), 1305 and 1145 (SO2, s), 1268 (m), 1202 (m), 886 (m), 836 (m), 707 (m), 
621 (m); MS (ASAP) m/z: 441.1 [M + H]
+
; HRMS (ASAP) m/z: [M + H]
+
 Calcd. for 
C25H21N4O2S 441.1380; Found: 441.1374. 
1,9-diamino-3,7-dicyano-5,5-dioxo-5H-dibenzo[b,d]thiophene (9): To a stirred solution of 
SnCl2.2H2O (5.07 g, 22.5 mmol) in a mixture of ethanol (14 mL) and aqueous HCl (2 M, 14 
mL), 5 (0.50 g, 1.40 mmol) was added. The mixture was heated to 85 °C for 2.5 h then 
cooled to room temperature and poured into aqueous HCl (2 M, 56 mL). An orange 
precipitate immediately formed which was filtered and washed with hexane (30 mL). The 
product was purified by silica column chromatography (eluent: started 30:70 hexane: ethyl 
acetate (v/v) gradually increased polarity to 100% ethyl acetate) to afford 9 as a light brown 
powder (60 mg, 14%). Mp: 300 °C (dec.); 
1
H NMR (400 MHz, DMSO-D6, ppm) δ = 7.79 
(2H, d, J = 1.5 Hz, H4/6), 7.52 (2H, d, J = 1.5 Hz, H2/8), 6.60 (4H, s, ‒NH2); 
13
C NMR (101 
MHz, DMSO- D6, ppm) δ = 145.0, 139.1, 126.5, 118.1, 117.6, 112.9, 112.6; IR (νmax/cm
-1
 ) 
3451 and 3360 (N-H, m), 3243 (w), 3070 (w), 2226 (C≡N, s), 1632 and 1598 (NH2, s), 1543 
(m), 1467 (m), 1430 (m),  1346 (m), 1299 and 1143 (SO2, s), 1253 (m), 1194 (m), 881 (m), 
617 (m).  MS (ASAP) m/z: 297.0 [M + H]
+
; HRMS (ASAP) m/z: [M + H]
+
 Calcd. for 
C14H9N4O2S 297.0441; Found: 297.0437. 
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Figure S1 Absorption (solid line) and emission spectra (dashed line) for compounds 5‒8 in 
CHCl3 solution. 
 
Table S1 Absorption and emission peak maxima for compounds 5‒8. 
 CH3CN CHCl3 
compd     
   
 (nm)     
  
 (nm)     
   
 (nm)     
  
 (nm) 
5 309, 347 n/a
a 
309, 345 n/a
a 
6 312, 368, 439 535 313, 348(sh), 361, 431 512 
7 312, 369, 442 538 313, 352(sh), 364, 432 512 
8 316, 344(sh), 425  482 316, 344(sh), 414, 426  474 
a 
No emission observed for 5.
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X-Ray crystallography 
X-ray diffraction experiments were carried out at T=120 K on a Bruker 3-circle D8 Venture 
diffractometer with a PHOTON 100 CMOS area detector, using Mo-K radiation (λ=0.71073 
Å) from an Incoatec IμS microsource with focusing mirrors and a Cryostream (Oxford 
Cryosystems) open-flow N2 gas cryostat. Crystallization of 5 from ethyl acetate/hexane 
solution yielded two concomitant polymorphs, orthorhombic (o-5) and tetragonal (t-5), 
whereas crystallization from THF/methanol/water solution gave crystals of 5·½THF 
systematically twinned by 180° rotation about the z axis. The structure of 5·½THF is shown 
below (Figure S3). The reflections of 5·½THF were indexed using CELL_NOW 2008/4 
program and scaled using TWINABS program (Bruker AXS, 2012). Crystals of 6 were 
grown from ethyl acetate/hexane solution. Structures o-5 and 6 were solved by direct 
methods (SHELXS),
1
 t-5 by charge-flipping method (SUPERFLIP),
2–4
 5·½THF by dual-
space intrinsic phasing (SHELXT).
5
 All structures were refined by full-matrix least squares 
using SHELXL
6
 software on OLEX2
7
 platform. Selected crystal data are listed in Table S2, 
full data (including structure factors) have been deposited with Cambridge Structural 
Database. 
 
Figure S2 X-ray molecular structure of 5·½THF. Thermal ellipsoids are drawn at the 50% 
probability level, disorder of THF is omitted. Primed atoms are generated by inversion center. 
The asymmetric unit of o-5 comprises one molecule in a general position. In 5·½THF, the 
THF molecule is located at a crystallographic inversion center, i.e. is disordered between two 
overlapping positions related by this center, while molecule 5 occupies a general position. 
Structure t-5 contains two symmetrically non-equivalent molecules, A and B, both lying 
S13 
 
astride crystallographic 2-fold axes but not actually having the C2 symmetry, the sulfur atoms 
being shifted off this axis by 0.14 Å (A) or 0.17 Å (B). In all three structures, as in earlier 
studied derivatives with nitro-groups in positions 1 and 9,
8–11
 molecule 5 is strongly distorted 
in order to widen the N(2)…N(3) and N…O separations between these nitro-groups, with the 
two arene rings mutually twisted and the C–NO2 bonds further tilted out of the corresponding 
arene planes in opposite directions (see Table S3). On the contrary, in 1,3-diazepine 6 the 
arene rings and N(2) and N(3) are nearly coplanar. The 1,3-diazepine ring adopts an envelope 
conformation with C(15) tilted by 0.67 Å from the plane of the other six atoms. 
 
Figure S3 Two independent molecules of 5 in the tetragonal polymorph (disorder is not 
shown). Primed atoms are generated by symmetry transformations (i) 1–x, –y, z, and (ii) 1–x, 
1–y, z, i.e. rotations about twofold axes, 
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Figure S4 Disorder in the crystal structure of the tetragonal 5  
Curiously, the orthorhombic form of 5, which crystallized first and should be metastable 
according to Ostwald’s rule of stages, has higher density (see Table S2) than the tetragonal 
polymorph into which it recrystallized later – as the denser forms are usually the more stable 
ones. 
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Table S2. Crystal data (at T=120 K) and experimental details 
Compound  o-5  t-5  5·½THF 6  
Local depository no. 16srv075 16srv083 15srv108 16srv076 
CCDC no. 1850071  1850073  1854413  1850072  
Formula  C14H4N4O6S  C14H4N4O6S  C16H8N4O6.5S  C17H12N4O2S  
Dcalc./ g cm
-3
  1.681  1.618  1.635  1.439  
/mm-1  0.275  0.265  0.254  0.226  
Formula weight  356.27  356.27  392.32  336.37  
Crystal system  orthorhombic  tetragonal  monoclinic  monoclinic  
Space group  Pbca (#61) P42bc (#106) P21/c (#14) C2/c (#15) 
a/Å  9.9204(7)  10.4555(9)  13.3642(9)  19.8345(10)  
b/Å  11.0141(8)  10.4555(9)  9.6436(6)  9.7054(5)  
c/Å  25.763(2)  26.750(2)  13.6194(9)  17.1644(8)  
/°  90  90  114.786(2)  109.942(2)  
V/Å
3
  2815.0(4)  2924.2(6)  1593.6(2)  3106.0(3)  
Z  8  8  4  8  
θmax/°  60  55  60  64 
Reflections measured  32632  47341  14526  37838  
                independent  4131  3349  5431  5434  
                with I > 2σ(I)  3430  3264  4437  4545  
Rint  0.041  0.049  0.064  0.036  
Parameters, restraints  226, 0  232, 175  264, 19  229, 0  
R1 [I > 2σ(I)] 0.037  0.059  0.057  0.041  
wR2 (all data)  0.095  0.153  0.123  0.111  
Goodness of fit  1.045  1.162  1.075  1.055  
Δρmax,min/ eÅ
–3
 0.42, -0.44  0.60, -0.40  0.45, -0.65  0.54, -0.34  
 
Table S3. Distortion of dibenzothiophene systems 
 o-5  t-5, A  t-5, B 5·½THF 6  
Arene/arene twist, ° 18.3 18.4 18.3 14.6 3.3 
Arene/C–N tilt, ° 8.0, –14.0 11.1, –11.1 10.5, –10.5 9.4, –12.3 3.3, 4.1 
N(2)…N(3), Å 3.001(2) 2.906(7) 2.947(7) 2.901(3) 2.425(2) 
N…O, Å 2.632(2) 2.587(7) 2.614(7) 2.631(3) --- 
 2.717(2)   2.635(3) --- 
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Computational studies of diamine 9 
Computational experimental details can be found in the general experimental in the main text. 
 
Figure S5 Calculated (B3LYP/6-31G*) optimized geometry for diamine 9. 
 
 
Figure S6 Molecular orbital profiles and energies for the frontier orbitals of diamine 9. 
  
HOMO = ‒6.509 eV 
LUMO = ‒2.798 eV 
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Other computational data 
Structure of input file for geometry optimization and frequency calculation for 5: 
! B3LYP 6-31G* OPT FREQ NormalPrint Grid4  TightSCF  
%scf 
 MaxIter 125 
 CNVDIIS 1 
 CNVSOSCF 1  
end 
%output 
 print[p_mos] true 
 print[p_basis] 5 
end 
* xyz 0 1 
   C        2.62669       -2.12262       -0.39208 
   C        1.85077       -3.24357       -0.04933 
   C        0.47211       -3.13028        0.12844 
   C        2.00278       -0.86283       -0.49469 
   C        0.63238       -0.82129       -0.34691 
   C       -0.21292       -1.91891       -0.10947 
   C       -1.90947       -0.18509        0.00021 
   C       -1.66521       -1.56594       -0.09599 
   C       -2.83368       -2.34835       -0.22099 
   C       -4.10689       -1.79973       -0.06896 
   C       -3.14326        0.41995        0.11500 
   C       -4.27614       -0.41863        0.13103 
   H       -4.96526       -2.45487       -0.13880 
   H       -3.24154        1.49699        0.18014 
   S       -0.31917        0.81278       -0.24697 
   C        4.03794       -2.25230       -0.58085 
   N       -6.65534        0.58451        0.42768 
   N       -0.18788       -4.30722        0.72274 
   O        0.32528       -5.44092        0.52521 
   O       -1.19758       -4.08806        1.46015 
   N       -2.79956       -3.75311       -0.66777 
   O       -1.82049       -4.10003       -1.39744 
   O       -3.76863       -4.49859       -0.36332 
   N        5.19206       -2.35648       -0.73716 
   C       -5.58543        0.13197        0.29431 
   O       -0.41896        1.62140       -1.70173 
   O        0.17553        1.63280        1.11783 
   H        2.58030        0.03645       -0.67257 
   H        2.31662       -4.20676        0.11232 
* 
Number of imaginary frequencies = 0  Total energy = ‒43630.82109 eV 
 
 
 
S18 
 
Structure of input file for geometry optimization and frequency calculation for 6: 
! B3LYP 6-31G* OPT FREQ NormalPrint Grid4  TightSCF  
%scf 
 MaxIter 125 
 CNVDIIS 1 
 CNVSOSCF 1  
end 
%output 
 print[p_mos] true 
 print[p_basis] 5 
end 
* xyz 0 1 
   C        2.54980       -2.10102       -0.32557 
   C        1.73289       -3.23548       -0.22420 
   C        0.33276       -3.13835       -0.10331 
   C        1.96899       -0.83663       -0.30286 
   C        0.59575       -0.73144       -0.14964 
   C       -0.23971       -1.85604       -0.04889 
   C       -1.87775       -0.09909        0.06039 
   C       -1.67937       -1.48974        0.04467 
   C       -2.80017       -2.34124        0.05160 
   C       -4.08277       -1.75896        0.11033 
   C       -3.13827        0.47828        0.13944 
   C       -4.25299       -0.36545        0.18069 
   H       -4.95426       -2.40281        0.08448 
   H       -3.24976        1.55658        0.14640 
   S       -0.34907        0.74731       -0.12191 
   C        3.97502       -2.22390       -0.49545 
   N       -6.62327        0.68541        0.31102 
   N       -0.41640       -4.33575       -0.24898 
   N       -2.72972       -3.73808       -0.19480 
   N        5.12170       -2.29907       -0.63265 
   C       -5.57286        0.20328        0.25377 
   O       -0.25368        1.53843       -1.43832 
   O        0.00645        1.69146        1.03315 
   C       -1.73625       -4.70832        0.23786 
   C       -2.09566       -6.05383       -0.44402 
   C       -1.79038       -5.04409        1.75548 
   H       -1.56487       -4.20634        2.43289 
   H       -1.08986       -5.88441        1.98750 
   H       -2.79781       -5.45145        2.02287 
   H       -2.09011       -5.93428       -1.54843 
   H       -3.11041       -6.39707       -0.15210 
   H       -1.35440       -6.84181       -0.19132 
   H        2.17663       -4.18824       -0.24941 
   H        2.56188        0.02597       -0.40412 
   H        0.03654       -5.03694       -0.77091 
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   H       -3.46302       -4.10450       -0.74000 
* 
Number of imaginary frequencies = 0  Total energy = ‒38692.35407 eV 
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Structure of input file for geometry optimization and frequency calculation for 9: 
! B3LYP 6-31G* OPT FREQ NormalPrint Grid4  TightSCF  
%scf 
 MaxIter 125 
 CNVDIIS 1 
 CNVSOSCF 1  
end 
%output 
 print[p_mos] true 
 print[p_basis] 5 
end 
* xyz 0 1 
   C        2.51397       -2.16361       -0.39997 
   C        1.69730       -3.29329       -0.50994 
   C        0.29345       -3.21792       -0.40498 
   C        1.94875       -0.89697       -0.15375 
   C        0.57507       -0.84303       -0.04713 
   C       -0.28692       -1.94789       -0.17546 
   C       -1.91683       -0.20544        0.12080 
   C       -1.71220       -1.58326       -0.07903 
   C       -2.85294       -2.41323       -0.19116 
   C       -4.12242       -1.80448       -0.11620 
   C       -3.14994        0.40765        0.18977 
   C       -4.27797       -0.42593        0.05831 
   H       -5.01043       -2.42488       -0.20066 
   H       -3.25329        1.47764        0.33059 
   S       -0.35134        0.66842        0.25022 
   C        3.93513       -2.30813       -0.52614 
   N       -6.67216        0.57546        0.16322 
   N       -0.45059       -4.37235       -0.58572 
   N       -2.78124       -3.77646       -0.42398 
   N        5.08701       -2.43346       -0.62922 
   C       -5.59816        0.13105        0.11683 
   O       -0.18684        1.60545       -0.86800 
   O       -0.13913        1.13602        1.62655 
   H        2.16161       -4.25960       -0.68678 
   H        2.56797       -0.01189       -0.06113 
   H        0.12256       -5.20057       -0.68950 
   H       -3.68812       -4.22640       -0.43186 
   H       -1.43468       -4.38607       -0.61069 
   H       -1.93497       -4.25872       -0.56719 
* 
Number of imaginary frequencies = 0  Total energy = ‒35517.95341 eV 
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Electrochemistry        
 
Table S4 Cyclic Voltammetry Data for 5
a
, S1
b
 and S2
b
 
compd E1red
1/2
 (V) E2red
1/2
 (V) E3red
1/2
 (V) ΔE1−2 (V) Kdispr
c
 (M
-1
) EA
d
 (eV) 
5 −0.15 −0.45  0.30 8.210-6 2.39 
S1 −0.27 −0.64 −1.33 0.37 5.410-7 2.27 
S2 +0.17 −0.45 −1.04 0.62 3.110-11 2.71 
a 
Solvent acetonitrile; electrolyte 0.10 M (n-Bu4N)(PF6); scan rate 100 mV s
-1
. All potentials have been 
recalculated to the Ag/AgCl scale using the Fc
0
/Fc
+
 couple as internal reference. 
b 
Experimental
 
conditions as 
above but using 0.20 M (Et4N)(BF4). 
c
 Calculated using the equation ΔE1−2 = E1red
1/2
 – E2red
1/2
 = −0.059 log Kdispr. 
d 
Calculated using the equation EA
ref
 – EA = E1red
1/2
 (ref) – E1red
1/2 
using the EA of the strongest acceptor 3 as 
EA
ref
. 
The first reduction potential of 5 is intermediate between that of S1 and S2; however, the 
second reduction occurs at the same potential for 5 and S2.  In contrast to S1 and S2 a third 
reduction is not observed for the sulfone 5 indicating that the tetrahedral sulfone does not 
function as a formal single-electron acceptor in the same manner as the planar carbonyl S1 
and dicyanomethylene S2 moieties. 
The separation between the first two reduction waves for 5 is significantly (S1) or very 
significantly (S2) smaller in both instances. This was used to calculate the disproportionation 
constant Kdispr which provides an indication of the stability of the radical anion versus the 
dianion state.
10,12,13
 Kdispr for 5 and S1 is 4 to 5 orders of magnitude lower than that of S2. 
This highlights that the dicyanomethylene group of S2 is very efficient at stabilizing the 
radical anion of S2. When considered alongside the relative reduction potentials, this also 
indicates that for S2 the first reduction will be centered on the dicyanomethylene unit, while 
for 5 and S1 at least the first reduction will involve the aromatic skeleton. The higher first 
reduction potential and electron affinity (EA) for 5 compared to S1 also demonstrates the 
stronger electron withdrawing ability of the sulfone compared to the carbonyl group. 
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As shown in Figures S8 and S9, reversibility in both the first and second reductions of 5 was 
confirmed by the linear relationship between scan rate and peak current. Lines of best fit 
demonstrated an adjusted R
2
 value of >0.9998 in both cases. 
 
Figure S7 Cyclic voltammograms of 5 obtained at varying scan rates. 
 
Figure S8 Relationship between peak current and the square root of the scan rate for both 
reduction processes for 5, confirming high reversibility.  
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